Skip to search
Skip to main content
Back to Search
Start Over
Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy
Authors :
Russo, Domenico Rosti, G Martinelli, G Malagola, Michele Mirto, S Turri, D Gobbi, M Pierri, I Vitolo, U Pregno, P Di Raimondo, F Stagno, F Foà, R Alimena, G Breccia, M Rambaldi, A Intermesoli, T Saglio, G Rege Cambrin, G Visani, G Nicolini, G De Fabritiis, P Abruzzese, E Nobile, F Martino, B Fanin, R Tiribelli, M Galieni, P Bigazzi, C Liso, V Specchia, G Angelucci, E Usala, E Musolino, C Russo, S Gaidano, G Lunghi, M Lauria, F Bocchia, M Quarta, G Girasoli, M Bosi, A Santini, V Fioritoni, G Di Lorenzo, R Colombi, C Fogli, M Amabile, M De Vivo, A B. a. c. c. a. r. a. n. i. M.
Publication Year :
2009
Publisher :
Ferrata Storti Foundation, 2009.
Details
Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3662..ebfe011fc85863d1b500b9220afcfcb2